Silk Road Medical Appoints William Hill as General Counsel
Silk Road Medical (NASDAQ: SILK) announced the appointment of William Hill as General Counsel on April 15, 2021. Hill brings extensive experience from over 14 years as General Counsel at Natus Medical, managing various legal issues including risk management and compliance. His role will include overseeing legal matters as Silk Road continues to advance its innovative TransCarotid Artery Revascularization (TCAR) therapies. CEO Erica Rogers expressed confidence in Hill's expertise to support their mission in stroke risk reduction.
- William Hill's extensive experience as General Counsel at Natus Medical is expected to strengthen Silk Road's legal strategy.
- Hill's background in managing global legal issues will enhance risk management and compliance efforts.
- None.
SUNNYVALE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the appointment of William Hill as General Counsel. The veteran corporate executive joins the company to oversee all risk management and legal matters, reporting directly to President and Chief Executive Officer, Erica Rogers.
“As we continue to usher in a new era of transcarotid therapies, we look forward to benefitting from Bill’s knowledge on a broad range of legal matters in healthcare and the regulated environment in which we operate,” said Erica Rogers.
Prior to joining Silk Road Medical, Mr. Hill served as General Counsel for Natus Medical Incorporated for over 14 years. He was responsible for managing a broad range of global legal issues, including corporate-wide liability mitigation and international legal compliance strategies, mergers and acquisitions, general commercial law and litigation, and employment law.
Mr. Hill began his legal career in the mass tort department at Porzio, Bromberg, & Newman P.C. in New Jersey where he assisted with product liability, FDA, and pharmaceutical litigation matters. He has also performed pro bono legal work for the Pro Bono Project of Silicon Valley supporting underrepresented communities in family law cases. Mr. Hill graduated from the University of Maryland School of Law where he served as a summer clerk at the United States District Court. He completed his undergraduate education at the University of North Carolina at Chapel Hill.
About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.
| Investors: | Media: |
| Lynn Lewis or Caroline Paul | Michael Fanucchi |
| Gilmartin Group | Silk Road Medical |
| investors@silkroadmed.com | mfanucchi@silkroadmed.com |
FAQ
Who is the new General Counsel of Silk Road Medical?
What is the experience of William Hill before joining Silk Road Medical?
What impact will William Hill's appointment have on Silk Road Medical?
When was William Hill appointed as General Counsel of Silk Road Medical?
What is the focus of Silk Road Medical's therapies?
